Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | NP137 |
Trade Name | |
Synonyms | NP 137|NP-137 |
Drug Descriptions |
NP137 is a humanized monoclonal antibody against netrin-1, which blocks netrin-1 binding to its receptors, potentially leads to dependence receptor (DR)-induced apoptosis (Cancer Res 2015;75(15 Suppl):Abstract nr 2921). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179293 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + NP137 + Paclitaxel | Carboplatin NP137 Paclitaxel | 0 | 1 |
Carboplatin + NP137 + Paclitaxel Trevatide + Pembrolizumab | Carboplatin NP137 Paclitaxel Trevatide Pembrolizumab | 0 | 1 |
NP137 | NP137 | 0 | 1 |
NP137 + Pembrolizumab | NP137 Pembrolizumab | 0 | 1 |
NP137 + unspecified PD-1 antibody | NP137 unspecified PD-1 antibody | 0 | 1 |
NP137 + unspecified PD-L1 antibody | NP137 unspecified PD-L1 antibody | 0 | 1 |